P/E ratio for Fortis Healthcare (FORTIS.NS)
P/E ratio as of May 2024 (TTM): 57.5
According to Fortis Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 57.5233. At the end of 2022 the company had a P/E ratio of 41.2.
P/E ratio history for Fortis Healthcare from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 41.2 | -2.52% |
| 2021 | 42.2 | -171.02% |
| 2020 | -59.5 | -289.35% |
| 2019 | 31.4 | -672.21% |
| 2018 | -5.49 | -89.09% |
| 2017 | -50.3 | -332.46% |
| 2016 | 21.6 | -73.93% |
| 2015 | 83.0 | -428.76% |
| 2014 | -25.2 | -134.72% |
| 2013 | 72.7 | 902.99% |
| 2012 | 7.25 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.